Veronique D/iStock Editorial via Getty Images A federal judge has denied a bid from Novartis to declare that the U.S. FDA's approval of a generic of its heart failure drug Entresto (sacubitril/valsartan) was unlawful.
Judge Dabney L. Friedrich of the U.S.
District Court for the District of Columbia.
